Drug Metabolism Reviews

Papers
(The H4-Index of Drug Metabolism Reviews is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
CYP24A1: the pivotal regulator of vitamin D homeostasis, pathophysiology in metabolic and genetic disease, and emerging target for precision medicine53
Drug transporters in drug disposition – the year 2022 in review48
Mechanisms of intestinal pharmacokinetic natural product-drug interactions41
Phase II metabolism in xenobiotic biotransformation: general mechanisms and the underestimated role of microbial systems36
An in-depth review of PPARγ modulators as anti-diabetes therapeutics23
Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models22
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids20
New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments18
A critical review of analytical tools for the detection of spironolactone and its metabolites16
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations15
Cytochrome P450-mediated carbon-carbon bond formation in drug metabolism15
Multimolecular interactions from Chinese medicines activate nuclear receptor conformational changes: a potential strategy for anti-inflammatory therapy14
Biopolymers as promising vehicles for drug delivery to the brain13
Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance13
0.17649793624878